SCOTT JOHNSON: Open Payments
NPI 1609833219 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$839 in 18 payments from 11 companies in 2025. Trend: 2023 $145 · 2024 $450 · 2025 $839
Food & beverage: $804Education: $35
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $234 |
| UROGEN PHARMA, INC. | 3 | $175 |
| Procept Biorobotics Corporation | 1 | $124 |
| Ferring Pharmaceuticals Inc. | 4 | $122 |
| AXOGEN | 2 | $61 |
| AstraZeneca Pharmaceuticals LP | 1 | $35 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| Verity Pharmaceuticals Inc. | 1 | $20 |
| TOLMAR, INC. | 1 | $19 |
| Antares Pharma, Inc. | 1 | $15 |
Products named: Axonics, AQUABEAM ROBOTIC SYSTEM, ADSTILADRIN, ZUSDURI, AMS 700, IMFINZI, AXOGUARD HA+ NERVE PROTECTOR, JELMYTO.
Industry payments across MO — which companies pay providers there.
